ClinicalTrials.gg
RecruitingNCT07528144PROTECT-EVARUpdated Aug 13, 2026

Exoskeleton vs. Standard Lead Apron in EVAR Procedures

An interventional study of Exoskeleton-supported radiation protection system and Standard lead apron in Radiation Exposure to Operator, Endovascular Aortic Repair and Musculoskeletal Strain, sponsored by Samodzielny Publiczny Szpital Kliniczny nr 2 PUM. Recruiting at 1 site in Poland. Open to participants aged 35 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by Samodzielny Publiczny Szpital Kliniczny nr 2 PUM · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Nov 2025, registered Apr 2026).
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether an exoskeleton-supported radiation protection system can reduce radiation exposure and musculoskeletal strain in vascular surgeons during endovascular aortic repair procedures, compared with standard lead aprons. Researchers will compare procedures performed with exoskeleton-supported protection and procedures performed with standard lead aprons. Radiation exposure, physical strain, fatigue, and discomfort will be assessed during and after procedures.

Read the detailed description

This is a prospective, randomized, controlled crossover study evaluating an exoskeleton-supported radiation protection system versus standard lead aprons during complex endovascular aortic repair procedures. The study will be conducted at the Department of Vascular Surgery, University Clinical Hospital No. 2 in Szczecin, Pomeranian Medical University.

Two vascular surgeons will participate in the study and perform a total of 60 procedures, including EVAR, IBD-EVAR, and BEVAR. Before each procedure, the type of radiation protection will be randomly assigned: a standard lead apron or an exoskeleton-supported protective system with visor. Each procedure will be performed in full with the assigned protection system, without switching during the intervention.

Operator radiation exposure will be measured in real time using 3 personal dosimeters per operator. Musculoskeletal load will be assessed using shoulder load sensors. After each procedure, operators will complete standardized questionnaires evaluating fatigue and discomfort, including the Borg CR-10 scale, visual analog scale, and Nordic Questionnaire.

The primary objective is to determine whether the exoskeleton-supported protection system reduces operator radiation exposure and musculoskeletal strain during endovascular aortic repair procedures. The results may help improve occupational safety during complex fluoroscopy-guided vascular interventions.

02

Conditions studied

  • Radiation Exposure to Operator
  • Endovascular Aortic Repair
  • Musculoskeletal Strain
  • Occupational Radiation Exposure

Browse trials for

Keywords

  • EVAR
  • BEVAR
  • IBD-EVAR
  • Exoskeleton
  • Lead Apron
  • Occupational Safety
  • Ionizing Radiation
  • Vascular Surgeon
  • Ergonomics
03

In context

Sprains and Strains

246 studies on the registry are indexed under Sprains and Strains; 49 are open to participants now.

This study's planned enrollment of 2 is below the median of 60 across 162 interventional studies indexed under Sprains and Strains.

Browse Sprains and Strains studies →

Lead sponsor

Samodzielny Publiczny Szpital Kliniczny nr 2 PUM is the lead sponsor of 2 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 35 years or older
  • written obtained
  • vascular surgeon with substantial experience in endovascular procedures
  • active participation in endovascular aortic repair procedures as a primary operator or assistant
  • high procedural volume in endovascular interventions

Exclusion criteria

Exclusion Criteria:

  • refusal or inability to provide
  • medical to the use of standard lead aprons or the exoskeleton-supported radiation protection system
  • health conditions preventing safe participation in study procedures
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
2 participants (estimated)

Study arms

  • Experimental
    Exoskeleton-Supported Protection System

    Endovascular aortic repair procedures performed with an exoskeleton-supported radiation protection system with visor.

    Device: Exoskeleton-supported radiation protection system

  • Active comparator
    Standard Lead Apron

    Endovascular aortic repair procedures performed with standard lead apron radiation protection.

    Device: Standard lead apron

Interventions

  • DeviceExoskeleton-supported radiation protection system

    An exoskeleton-supported radiation protection system with visor used by the operator during endovascular aortic repair procedures.

  • DeviceStandard lead apron

    A standard lead apron used by the operator during endovascular aortic repair procedures.

06

What researchers measure

Primary outcomes

  1. Operator musculoskeletal strain assessed during endovascular aortic repair procedures using shoulder load sensors.

    Operator weight distribution and physical load assessed during endovascular aortic repair procedures using foot-mounted load sensors.

    Time frame: During each procedure

  2. Operator radiation exposure

    Operator radiation exposure measured during endovascular aortic repair procedures using real-time personal dosimetry.

    Time frame: During each procedure

07

Study locations

1 of 1 sites recruiting
  • University Clinical Hospital No. 2, Pomeranian Medical University
    Szczecin, West Pomeranian Voivodeship 70-111, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because of the small sample size and the risk of participant identification.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Jun 2027, 19 months after the start.

Of 80 non-industry interventional studies with no phase under Sprains and Strains, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 35. This study's planned 19 months is above that.

Counting every sponsor, half of 82 studies reached it within 12 months; a quarter within 4 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 7, 2026
First posted
Apr 14, 2026
StartActual
Nov 3, 2025
Primary completionEst.
Jun 17, 2027
CompletionEst.
Jun 17, 2027
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07528144
Lead sponsor
Samodzielny Publiczny Szpital Kliniczny nr 2 PUM
Responsible party
Sponsor
First posted
Apr 14, 2026
Start date
Nov 3, 2025
Primary completion
Jun 17, 2027 (estimated)
Completion
Jun 17, 2027 (estimated)
Last update
Aug 13, 2026

Study contacts

Paweł Rynio, MD, PhD
Contact
p.rynio@usk2.szczecin.pl
914661156

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion